Bluestein R H & CO LLC Vertex Pharmaceuticals Inc Transaction History

Bluestein R H & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $226,918 - $253,940	-1,251 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $103,510 - $120,655	-500 Reduced 28.56%	1,251 $269,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $103,505 - $138,045	500 Added 39.97%	1,751 $414,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $306,780 - $363,720	-1,200 Reduced 48.96%	1,251 $340,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $248,028 - $325,380	1,100 Added 81.42%	2,451 $712,000
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $39,954 - $49,562	200 Added 17.38%	1,351 $321,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $191,883 - $257,720	1,151 New	1,151 $252,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Bluestein R H & CO LLC with notifications on news.